i want all the genes e.g in sample 1 to be concatenated as >1 likewise for my all samples
my thought is as all genes in all files are in same order so when i have multifasta as >1, >2, >3,>4,>5
i will take that multifasta to do alignment around these interval
Unconfigured Ad
Collapse
X
-
If you rename all of them as >1 or >2 for a sample the sequences ID's would no longer be unique.
What kind of MSA are you trying to do?
Leave a comment:
-
That won't give them unique deflines, which I think is what he/she is after for input to clustalw. I still can't tell what the problem is, though.Originally posted by GenoMax View PostYou want to convert every fasta ID header from multiple fasta sequences in file "a" to >1 and from file "b" to >2, is that correct?
Leave a comment:
-
You want to convert every fasta ID header from multiple fasta sequences in file "a" to >1 and from file "b" to >2, is that correct?
Leave a comment:
-
Do you want to know how to do the renaming or is this just an informational post?
Leave a comment:
-
MUltifasta file
hi every one,
what i need to do is i need multiple sequence alignment file
i converted the vcf file to consensus fasta and "cat" all these consensus sequence into multifasta.
in my cat file seq are >1......>10000 for a.fasta and >1......>10000 for b.fasta when i use clustal w it gives error that sequence have same header THAT MAKES SENSE so what i am planning to do is to convert >1..>2...>3.>10000 to >1
and >1..>2..>3..>10000 for b.fasta to >2 and same for for all my 5 samples
i have to use this file for multiple alignment
RegardsLast edited by huma Asif; 09-08-2014, 10:13 AM.Tags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
15 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
15 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
35 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: